Calidi Biotherapeutics, Inc.
CLDWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCLDI
Q3 2022 vs. Q2 2022
How the institutions holding Calidi Biotherapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 28 | 27 | −1 |
| Shares | 7.73M | 8.09M | +360.8K (+4.7%) |
| Value | $767.0K | $479.9K | −$287.1K (−37.4%) |
New holders (1)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Magnetar Financial LLC | 435,400 | $25.0K | 0.00% |
Sold out (2)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Woodline Partners LP | 437,431 | $39.0K |
| Highbridge Capital Management LLC | – | $33.0K |